Cargando…

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours

BACKGROUND: Use of cyclin D1 (CCND1) gene amplification as a breast cancer biomarker has been hampered by conflicting assessments of the relationship between cyclin D1 protein levels and patient survival. Here, we aimed to clarify its prognostic and treatment predictive potential through comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundberg, Arian, Lindström, Linda S., Li, Jingmei, Harrell, J. Chuck, Darai-Ramqvist, Eva, Sifakis, Emmanouil G., Foukakis, Theodoros, Perou, Charles M., Czene, Kamila, Bergh, Jonas, Tobin, Nicholas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394106/ https://www.ncbi.nlm.nih.gov/pubmed/30819233 http://dx.doi.org/10.1186/s13058-019-1121-4

Ejemplares similares

Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer
por: Li, Jingmei, et al.
Publicado: (2018)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease
por: Zerdes, Ioannis, et al.
Publicado: (2020)

PD-1 protein and gene expression as prognostic factors in early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2020)

STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
por: Zerdes, Ioannis, et al.
Publicado: (2019)

Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function
por: Sugawara, Tomonori, et al.
Publicado: (2016)

PReS-FINAL-2305: Erythema multiforme in a child with lupus - what's in a name?
por: Khubchandani, R, et al.
Publicado: (2013)

Effects of Lactobacillus gasseri CP2305 on Mild Menopausal Symptoms in Middle-Aged Women
por: Sawada, Daisuke, et al.
Publicado: (2022)

2305. The effect of SARS-CoV-2 antibody testing on the results of admission screening
por: Ota, Kenji, et al.
Publicado: (2023)

Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma
por: Klevebring, Daniel, et al.
Publicado: (2014)

PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES
por: Knoebl, P., et al.
Publicado: (2022)

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
por: Milosevic, Jelena, et al.
Publicado: (2013)

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms
por: Tobin, Nicholas P., et al.
Publicado: (2012)

2305: Advancement of translational sciences: Development of an interprofessional program and outcome measures for foundational, clinical, and health care researchers
por: Devi, Gayathri, et al.
Publicado: (2018)

Reclassifying tumour cell cycle activity in terms of its tissue of origin
por: Lundberg, Arian, et al.
Publicado: (2022)

MicroRNA, Pm-miR-2305, Participates in Nacre Formation by Targeting Pearlin in Pearl Oyster Pinctada martensii
por: Jiao, Yu, et al.
Publicado: (2015)

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
por: Chrétien, Sebastian, et al.
Publicado: (2019)

Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
por: Chen, Xinsong, et al.
Publicado: (2022)

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
por: Zerdes, Ioannis, et al.
Publicado: (2018)

Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study
por: Boman, Caroline, et al.
Publicado: (2022)

GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production
por: Miller, Corin, et al.
Publicado: (2017)

The Prognostic Value and Overexpression of Cyclin A Is Correlated with Gene Amplification of both Cyclin A and Cyclin E in Breast Cancer Patient
por: Husdal, A., et al.
Publicado: (2006)

Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women
por: Li, Jingmei, et al.
Publicado: (2017)

A comprehensive tool for measuring mammographic density changes over time
por: Eriksson, Mikael, et al.
Publicado: (2018)

FGFR4 Gly(388)Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
por: Xu, Bin, et al.
Publicado: (2011)

2305. Incidence of Active Cytomegalovirus Infection and Its Influence on Outcome Among Non-Immunosuppressed Cirrhotic Adults Requiring Critical Care in Liver-ICU
por: Shah, Dhara B, et al.
Publicado: (2019)

Separation of breast cancer and organ microenvironment transcriptomes in metastases
por: Alzubi, Mohammad A., et al.
Publicado: (2019)

Cyclin alterations in diverse cancers: outcome and co-amplification network
por: Schwaederlé, Maria, et al.
Publicado: (2014)

Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas
por: Akama, Yoshihiko, et al.
Publicado: (1995)

Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma
por: Darai-Ramqvist, Eva, et al.
Publicado: (2013)

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
por: Tobin, N. P., et al.
Publicado: (2015)

Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study
por: Nishida, Kensei, et al.
Publicado: (2019)

2305. Staphylococcus aureus Screening and Decolonization for Pediatric Patients Undergoing Cardiovascular Surgery at Texas Children’s Hospital (TCH): A Trainee Quality Improvement Initiative
por: Foster, Catherine, et al.
Publicado: (2018)

LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
por: Babiker, Abdel G, et al.
Publicado: (2022)

Effects of childhood body size on breast cancer tumour characteristics
por: Li, Jingmei, et al.
Publicado: (2010)

Common genetic variation and novel loci associated with volumetric mammographic density
por: Brand, Judith S., et al.
Publicado: (2018)

Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
por: Matikas, A, et al.
Publicado: (2019)

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
por: Zhu, Yajing, et al.
Publicado: (2022)

Is Genetic Background Important in Lung Cancer Survival?
por: Lindström, Linda S., et al.
Publicado: (2009)

Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns
por: Ugalde‐Morales, Emilio, et al.
Publicado: (2020)

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide
por: von Stedingk, Hans, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9founsv0di7h0vil612236bvk6